Siekierka J J, Wiederrecht G, Greulich H, Boulton D, Hung S H, Cryan J, Hodges P J, Sigal N H
Department of Immunology Research, Merck, Sharp & Dohme Research Laboratories, Rahway, New Jersey 07065.
J Biol Chem. 1990 Dec 5;265(34):21011-5.
We have recently isolated an abundant cytosolic protein from human T-cells which specifically binds the immunosuppressive agent, FK-506. The FK-506-binding protein (FKBP) is a member of a novel class of proteins possessing peptidyl-prolyl cis-trans isomerase activity. These proteins are believed to play an important role in accelerating the rate at which proteins fold into their native conformations. In the present study, we demonstrate that FKBP is not a lymphoid-specific protein, but is widely distributed and phylogenically conserved. FKBP, purified from three sources (a human T-lymphocyte cell line JURKAT, bovine calf thymus, and Saccharomyces cerevisiae) exhibit identical molecular weights, immunological cross-reactivities, and a high degree of NH2-terminal amino acid sequence homology. In addition, FKBP from all sources possesses peptidyl-prolyl cis-trans isomerase activity which can be specifically inhibited by FK-506. We conclude that FKBP may serve an important biological function in all eukaryotic cells.
我们最近从人T细胞中分离出一种丰富的胞质蛋白,它能特异性结合免疫抑制剂FK-506。FK-506结合蛋白(FKBP)是一类具有肽基脯氨酰顺反异构酶活性的新型蛋白质成员。这些蛋白质被认为在加速蛋白质折叠成其天然构象的速率方面发挥重要作用。在本研究中,我们证明FKBP不是淋巴细胞特异性蛋白,而是广泛分布且在系统发育上保守的。从三种来源(人T淋巴细胞系JURKAT、牛犊胸腺和酿酒酵母)纯化的FKBP表现出相同的分子量、免疫交叉反应性以及高度的NH2末端氨基酸序列同源性。此外,来自所有来源的FKBP都具有肽基脯氨酰顺反异构酶活性,该活性可被FK-506特异性抑制。我们得出结论,FKBP可能在所有真核细胞中发挥重要的生物学功能。